These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33087128)

  • 1. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
    Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
    BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
    Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
    BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
    Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
    PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
    Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
    BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
    Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
    BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
    N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of Envisia: a genomic classifier for usual interstitial pneumonia.
    Choi Y; Lu J; Hu Z; Pankratz DG; Jiang H; Cao M; Marchisano C; Huiras J; Fedorowicz G; Wong MG; Anderson JR; Tom EY; Babiarz J; Imtiaz U; Barth NM; Walsh PS; Kennedy GC; Huang J
    BMC Pulm Med; 2017 Nov; 17(1):141. PubMed ID: 29149880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
    Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
    Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
    Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
    Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
    Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
    Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
    Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms.
    Hao Y; Duh QY; Kloos RT; Babiarz J; Harrell RM; Traweek ST; Kim SY; Fedorowicz G; Walsh PS; Sadow PM; Huang J; Kennedy GC
    BMC Syst Biol; 2019 Apr; 13(Suppl 2):27. PubMed ID: 30952205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
    Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
    BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
    Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
    JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
    J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
    Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
    JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
    D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
    Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience.
    Zhang L; Smola B; Lew M; Pang J; Cantley R; Pantanowitz L; Heider A; Jing X
    Diagn Cytopathol; 2021 Aug; 49(8):921-927. PubMed ID: 34021740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.